Equity Compensation, Employment Agreements and Other Benefit Plans (Tables)

9 Months Ended

Sep. 30, 2020

Compensation Related Costs [Abstract]

Schedule of expenses related to equity-based compensation

The following table presents the Company’s expenses related to its equity-based compensation instruments for the three and nine months ended September 30, 2020 and 2019:

	Three Months Ended September 30,				Nine Months Ended September 30,
(In Thousands)	2020		2019		2020		2019
RSUs	$	2,267	$	1,288	$	5,094	$	4,724
Total	$	2,267	$	1,288	$	5,094	$	4,724

Schedule of expenses related to deferred compensation plans

The following table presents the Company’s expenses related to its Deferred Plans for the three and nine months ended September 30, 2020 and 2019:

	Three Months Ended September 30,				Nine Months Ended September 30,
(In Thousands)	2020		2019		2020		2019
Non-employee directors	$	75	$	134	$	(1,483)	$	459
Total	$	75	$	134	$	(1,483)	$	459

Schedule of aggregate income deferred by participants and associated liability under deferred compensation plans

The following table presents the aggregate amount of income deferred by participants of the Deferred Plans through September 30, 2020 and December 31, 2019 that had not been distributed and the Company’s associated liability for such deferrals at September 30, 2020 and December 31, 2019:

	September 30, 2020				December 31, 2019
(In Thousands)	Undistributed Income Deferred (1)		Liability Under Deferred Plans		Undistributed Income Deferred (1)		Liability Under Deferred Plans
Non-employee directors	$	2,074	$	1,114	$	2,349	$	3,071
Total	$	2,074	$	1,114	$	2,349	$	3,071

(1)  Represents the cumulative amounts that were deferred by participants through September 30, 2020 and December 31, 2019, which had not been distributed through such respective date.